Current through Register 2024 Notice Reg. No. 38, September 20, 2024
(a) Scope and Application.
(1) This section applies to all occupational
exposure to lead, except as provided in paragraph (a)(2).
(2) This section does not apply to the
construction industry or to agricultural operations.
(b) Definitions. For purposes of this
section, the definitions in section
5161 do not apply to the terms used
throughout this section.
Action Level. Employee exposure, without regard to the
use of respirators, to airborne lead at an 8-hour time-weighted average
concentration of 30 micrograms per cubic meter of air (30
µg/M3).
Chief. The Chief of the Division of Occupational Safety
and Health, P.O. Box 420603, San Francisco, California 94142.
Director. The Director, National Institute for
Occupational Safety and Health (NIOSH), U. S. Department of Health and Human
Services, or designee.
Lead. Metallic lead, all inorganic lead compounds, and
organic lead soaps. Excluded from this definition are all other organic lead
compounds.
(c) Permissible
Exposure Limit (PEL).
(1) The employer shall
assure that no employee is exposed to lead at an 8-hour time-weighted average
concentration greater than 50 micrograms per cubic meter of air (50
µg/M3).
(2) If an employee is exposed to lead for
more than 8 hours in any work day, the permissible exposure limit for that day,
as a time-weighted average concentration (TWA), shall be reduced according to
the following formula:
Maximum permissible limit (in
µg/M3) = 400 / hours worked in the
day.
(3) When respirators
are used to supplement engineering and work practice controls to comply with
the PEL, employee exposure, for the purpose of determining whether the employer
has complied with the PEL, may be considered to be at the level provided by the
protection factor of the respirator for those periods the respirator is worn.
Those periods may be averaged with exposure levels during periods when
respirators are not worn to determine the employee's daily TWA
exposure.
(d) Exposure
Monitoring.
(1) General.
(A) For the purposes of subsection (d),
employee exposure is that exposure which would occur if the employee were not
using a respirator.
(B) With the
exception of monitoring under subsection (d)(3), the employer shall collect
full shift (for at least 7 continuous hours) personal samples including at
least one sample for each shift for each job classification in each work
area.
(C) Full shift personal
samples shall be representative of the monitored employee's regular, daily
exposure to lead.
(2)
Initial Determination. Each employer who has a workplace or work operation
covered by this standard shall determine if any employee may be exposed to lead
at or above the action level.
(3)
Basis of Initial Determination.
(A) The
employer shall monitor employee exposures and shall base initial determinations
on the employee exposure monitoring results and any of the following, relevant
considerations:
1. Any information,
observations, or calculations which would indicate employee exposure to
lead;
2. Any previous measurements
of airborne lead; and
3. Any
employee complaints of symptoms which may be attributable to exposure to
lead.
(B) Monitoring for
the initial determination may be limited to a representative sample of the
exposed employees who the employer reasonably believes are exposed to the
greatest concentrations of airborne lead in the workplace.
(C) Measurements of airborne lead made in the
preceding 12 months may be used to satisfy the requirement to monitor under
subsection (d)(3)(A) if sampling and analytical methods used meet the accuracy
and confidence levels of subsection (d)(9).
(4) Positive Initial Determination and
Initial Monitoring.
(A) Where a determination
conducted under subsections (d)(2) and (d)(3) shows the possibility of any
employee exposure at or above the action level, the employer shall conduct
monitoring which is representative of the exposure for each employee in the
workplace who is exposed to lead.
(B) Measurements of airborne lead made in the
preceding 12 months may be used to satisfy this requirement if the sampling and
analytical methods used meet the accuracy and confidence levels of subsection
(d)(9).
(5) Negative
Initial Determination. Where a determination conducted under subsections (d)(2)
and (d)(3) is made that no employee is exposed to concentrations of airborne
lead at or above the action level, the employer shall make a written record of
such determination. The record shall include at least the information specified
in subsection (d)(3) and shall also include the date of determination, location
within the worksite, and the name and social security number of each employee
monitored.
(6) Frequency.
(A) If initial monitoring reveals an
employee's exposure to be above the permissible exposure limit, the employer
shall repeat monitoring quarterly until at least two consecutive measurements,
taken at least 7 days apart, are at or below the permissible exposure limit.
Subsequent monitoring for that employee shall conform with the applicable
provisions of subsections (d)(6)(B) or (C).
(B) If initial monitoring or monitoring
conducted in accordance with subsection (d)(6)(A) reveals an employee's
exposure to be at or above the action level but no greater than the permissible
exposure lmit, the employer shall repeat monitoring at least every 6 months.
The employer shall continue monitoring at the required frequency until at least
two consecutive measurements, taken at least 7 days apart, are below the action
level at which time the employer may discontinue monitoring for that employee
except as otherwise provided by subsection (d)(7).
(C) Whenever initial monitoring or monitoring
conducted in accordance with subsection (d)(6)(A) reveals an employee's
exposure to be below the action level, further measurements are not required
except as otherwise provided by subsection (d)(7).
(7) Additional Monitoring. Whenever there has
been a production, process, control or personnel change which may result in new
or additional exposure to lead, or whenever the employer has any other reason
to suspect a change which may result in new or additional exposures to lead,
additional monitoring in accordance with this subsection shall be
conducted.
(8) Employee
Notification.
(A) Within 5 working days after
the receipt of monitoring results, the employer shall notify each employee in
writing of the results which represent that employee's exposure.
(B) Whenever the results indicate that the
representative employee exposure, without regard to respirators, exceeds the
permissible exposure limit, the employer shall include in the written notice a
statement that the permissible exposure limit was exceeded and a description of
the corrective action taken or to be taken to reduce exposure to or below the
permissible exposure limit.
(9) Accuracy of Measurement. The employer
shall use a method of monitoring and analysis which has an accuracy (to a
confidence level of 95%) within plus or minus 20 percent at concentrations of
airborne lead equal to or greater than 30
µg/M3.
(e) Compliance.
(1) Methods.
(A) Where any employee is exposed to lead
above the permissible exposure limit for more than 30 days per year, the
employer shall implement engineering, work practice, and administrative
controls to reduce and maintain employee exposure to lead except to the extent
that the employer can demonstrate that such controls are not feasible. Where
engineering, work practice, and administrative controls which can be instituted
are not sufficient to reduce employee exposure to or below the permissible
exposure limit, they shall nonetheless be used by the employer to reduce
exposures to the lowest feasible level. Small non-ferrous foundries (fewer than
20 employees), however, are only required to achieve 75
µg/M3 by such controls.
(B) Where controls which can be instituted in
accordance with subsection (e)(1)(A) are not sufficient to reduce and maintain
employee exposure to or below the permissible exposure limit, the employer
shall supplement these controls with respiratory protection, in conformance
with subsection (f), to control employee exposure within the permissible
exposure limit.
(C) Where any
employee is exposed to lead above the permissible exposure limit, but for 30
days or less per year, the employer shall implement feasible engineering
controls to reduce exposure to 150 µg/M3, but
thereafter may implement any combination of engineering, work practice,
administrative and respiratory controls to reduce and maintain exposure to lead
to or below the permissible exposure limit.
(2) Compliance Program.
(A) Where applicable, each employer shall
establish and implement a written compliance program to reduce exposures to or
below the permissible exposure limit and interim levels solely by means of
engineering and work practice controls in accordance with the implementation
schedule in subsection (e)(1).
(B)
Written plans for these compliance programs shall include at least the
following:
1. A description of each operation
in which lead is emitted; e.g. machinery used, material processed, controls in
place, crew size, employee job responsibilities, operating procedures and
maintenance practices;
2. A
description of the specific means that will be employed to achieve compliance,
including engineering plans and studies used to determine methods selected for
controlling exposure to lead;
3. A
report of the technology considered in meeting the permissible exposure
limit;
4. Air monitoring data which
documents the source of lead emissions;
5. A detailed schedule for implementation of
the program, including documentation such as copies of purchase orders for
equipment, construction contracts, etc.;
6. A work practice program which includes
items required under subsections (g), (h), and (i);
7. An administrative control schedule
required by subsection (e)(5), if applicable; and
8. Other relevant
information.
(C) Written
programs shall be submitted upon request to the Chief and the Director, and
shall be available at the worksite for examination and copying by the Chief,
the Director, and any affected employee or authorized employee
representatives.
(D) Written
programs shall be revised and updated at least every 6 months to reflect the
current status of the program.
(3) [Reserved.]
(4) Mechanical Ventilation.
(A) When ventilation is used to control
exposure, measurements which demonstrate the effectiveness of the system in
controlling exposure, such as capture velocity, duct velocity, or static
pressure shall be made at least every 3 months. Measurements of the system's
effectiveness in controlling exposure shall be made within 5 days of any change
in production, process, or control which might result in a change in employee
exposure to lead.
(B) Recirculation
of Air. If air from exhaust ventilation is recirculated into the workplace, the
employer shall assure that:
1. The exhaust has
a high efficiency filter with a reliable back-up filter; and
2. Controls are installed, operating, and
maintained which monitor the concentration of lead in the return air and which,
in case of failure, automatically prevent the recirculation of exhaust
air.
(5)
Administrative Controls. If administrative controls are used as a means of
reducing employees' TWA exposure to lead, the employer shall establish and
implement a job rotation schedule which includes:
(A) Name or identification number of each
affected employee;
(B) Duration and
exposure levels at each job or work station where such affected employee is
located; and
(C) Any other
information which may be useful in assessing the reliability of administrative
controls to reduce exposure to lead.
(f) Respiratory Protection.
(1) General. For employees who are required
to use respirators by this section, the employer must provide respirators that
comply with the requirements of this subsection. Respirators must be used
during:
(A) Work operations for which
engineering and work practice controls are not sufficient to reduce exposures
to or below the permissible exposure limit;
(B) Periods necessary to implement
engineering or work practice controls.
(C) Periods when an employee requests a
respirator.
(2)
Respirator program.
(A) The employer must
implement a respiratory protection program in accordance with section
5144(c) (except
(d)(1)(C)) through (m).
(B) If an
employee exhibits breathing difficulty during fit testing or respirator use,
the employer must provide the employee with a medical examination in accordance
with subsection (j)(3)(A)3. to determine whether or not the employee can use a
respirator while performing the required duty.
(3) Respirator Selection.
(A) The employer shall select, and provide to
employees, the appropriate respirators specified in Section
5144(d)(3)(A)1.
(B) The employer shall provide a powered, air
purifying respirator in lieu of the respirator specified in subsection
(f)(3)(A) whenever:
1. An employee chooses to
use this type of respirator; and
2.
This respirator will provide adequate protection to the
employee.
(C) The
employer shall provide employees with full facepiece respirators instead of
half mask respirators for protection against lead aerosols that cause eye or
skin irritation at the use concentrations.
(D) The employer shall provide HEPA filters
for powered and non-powered air-purifying
respirators.
(g) Protective Work Clothing and Equipment.
(1) Provisions and Use. If an employee is
exposed to lead above the PEL, without regard to the use of respirators, or
where the possibility of skin or eye irritation exists, the employer shall
provide at no cost to the employee and assure that the employee uses
appropriate protective work clothing and equipment such as, but not limited to:
(A) Coveralls or similar full-body work
clothing;
(B) Gloves, hats, and
shoes or disposable shoe coverlets; and
(C) Face shields, vented goggles, or other
appropriate protective equipment which complies with Article
10.
(2) Cleaning and
Replacement.
(A) The employer shall provide
the protective clothing required in subsection (g)(1), in a clean and dry
condition at least weekly, and daily to employees whose exposure levels without
regard to respirator use are over 150 µg/M3 of
lead on an 8-hour time-weighted average basis.
(B) The employer shall provide for the
cleaning, laundering, or disposal of protective clothing and equipment required
by subsection (g)(1).
(C) The
employer shall repair or replace required protective clothing and equipment as
needed to maintain their effectiveness.
(D) The employer shall assure that all
protective clothing is removed at the completion of a work shift and only in
change rooms provided for that purpose as prescribed in subsection
(i)(2).
(E) The employer shall
assure that contaminated protective clothing which is to be cleaned, laundered,
or disposed of, is placed in a closed container in the change room which
prevents dispersion of lead outside the container.
(F) The employer shall inform in writing any
person who cleans or launders protective clothing or equipment of the
potentially harmful effects of exposure to lead.
(G) Labeling of contaminated protective
clothing and equipment.
1. The employer shall
ensure that labels of bags or containers of contaminated protective clothing
and equipment include the following information:
DANGER: CLOTHING AND EQUIPMENT CONTAMINATED WITH LEAD.
MAY DAMAGE FERTILITY OR THE UNBORN CHILD. CAUSES DAMAGE TO THE CENTRAL NERVOUS
SYSTEM. DO NOT EAT, DRINK OR SMOKE WHEN HANDLING. DO NOT REMOVE DUST BY BLOWING
OR SHAKING. DISPOSE OF LEAD CONTAMINATED WASH WATER IN ACCORDANCE WITH
APPLICABLE LOCAL, STATE, OR FEDERAL REGULATIONS.
2. Prior to June 1, 2015, employers may
include the following information on bags or containers of contaminated
protective clothing and equipment in lieu of the labeling requirements in
subsections (g)(2)(G)1. of this section:
CAUTION: | CLOTHING CONTAMINATED WITH LEAD.
DO NOT REMOVE DUST BY BLOWING OR SHAKING. DISPOSE OF LEAD CONTAMINATED WASH
WATER IN ACCORDANCE WITH APPLICABLE LOCAL, STATE OR FEDERAL REGULATIONS. |
(H) The employer shall prohibit the removal
of lead from protective clothing or equipment by blowing, shaking, or any other
means which disperses lead into the air.
Note: A downdraft booth, "air shower," or
other appropriate means for the removal of lead dust may be used provided
employee exposure to airborne lead dust is prevented during such
use.
(h)
Housekeeping.
(1) Surfaces. All surfaces
shall be maintained as free as practicable of accumulations of lead.
(2) Cleaning Floors.
(A) Floors and other surfaces where lead
accumulates may not be cleaned by the use of compressed air.
(B) Shoveling, dry or wet sweeping, and
brushing may be used only where vacuuming or other equally effective methods
have been tried and found not to be effective.
(3) Vacuuming. Where vacuuming methods are
selected, the vacuums shall be used and emptied in a manner which minimizes the
re-entry of lead into the workplace. Those vacuum systems which exhaust air
into the workplace shall be equipped with air filters at least as effective as
high efficiency particulate air filters. High efficiency particulate air filter
means 99.97% efficient against 0.3 micrometer size
particles.
(i) Hygiene
Facilities and Practices.
(1) The employer
shall assure that in areas where employees are exposed to lead above the PEL,
without regard to the use of respirators, food or beverage is not present or
consumed, tobacco products are not present or used, and cosmetics are not
applied, except in change rooms, lunchrooms, and showers required under
subsections (i)(2)-(i)(4).
(2)
Change Rooms.
(A) The employer shall provide
clean change rooms for employees who work in areas where their airborne
exposure to lead is above the PEL, without regard to the use of
respirators.
(B) The employer shall
assure that change rooms are equipped with separate storage facilities for
protective work clothing and equipment and for street clothes which prevent
cross contamination.
EXCEPTION: Separate storage facilities are not required
where clean protective clothing and equipment are provided on a daily
basis.
(3)
Showers.
(A) The employer shall assure that
employees who work in areas where their exposure to airborne lead is above the
PEL, without regard to the use of respirators, shower at the end of the work
shift.
(B) The employer shall
provide shower facilities in accordance with Section
3366(f).
(C) The employer shall assure that employees
who are required to shower pursuant to subsection (i)(3)(A) do not leave the
work place wearing any clothing or equipment worn during the work
shift.
(4) Lunchrooms.
(A) The employer shall provide readily
accessible lunchroom facilities, in accordance with Section
3368, for employees who work in
areas where their exposure to airborne lead is above the PEL, without regard to
the use of respirators.
(B)
Lunchroom facilities shall have a temperature controlled, positive pressure,
filtered air supply except that such facilities need not be under positive
pressure if workplace operations produce no contamination by airborne lead.
(Title 24, Part 2-1724(c)(1)(D)(2).)
(C) The employer shall assure that employees
who work in areas where their exposure to airborne lead is above the PEL,
without regard to respirator use, wash their hands and face prior to eating,
drinking, smoking or applying cosmetics.
(D) The employer shall assure that employees
do not enter lunchroom facilities with protective work clothing or equipment
unless surface lead dust has been removed by vacuuming, downdraft booth, or
other cleaning method.
(5) Lavatories. The employer shall provide an
adequate number of lavatory facilities which comply with Section
3366.
(j) Medical Surveillance.
(1) General.
(A) The employer shall institute a medical
surveillance program for all employees who are or may be exposed at or above
the action level for more than 30 days per year.
(B) The employer shall assure that all
medical examinations and procedures are performed by or under the supervision
of a licensed physician.
(C) The
employer shall provide the required medical surveillance including multiple
physician review under subsection (j)(3)(C) without cost to employees and at a
reasonable time and place.
(2) Biological Monitoring.
(A) Blood Lead and Zinc Protoporphrin
Sampling and Analysis. The employer shall make available biological monitoring
in the form of blood sampling and analysis for lead and zinc protoporphrin
(ZPP) levels to each employee covered under subsection (j)(1)(A) on the
following schedule:
1. At least every 6 months
to each employee covered under subsection (j)(1)(A);
2. At least every two months for each
employee whose last blood sampling and analysis indicated a blood lead level at
or above 40 µg/100 g of whole blood. This frequency shall continue until
two consecutive blood samples and analysis indicate a blood lead level below 40
µg/100 g of whole blood; and
3. At least monthly during the removal period
of each employee removed from exposure to lead due to an elevated blood lead
level.
4. ZPP determinations shall
be made available as soon as possible but no later than the first biological
monitoring scheduled for an employee.
(B) Follow-Up Blood Sampling Tests. Whenever
the results of a blood lead level test indicate that an employee's blood lead
level is at or above the numerical criterion for medical removal under
subsection (k)(1), the employer shall provide a second (follow-up) blood
sampling test within two weeks after the employer receives the results of the
first blood sampling test.
(C)
Accuracy of Blood Lead Level Sampling and Analysis. Blood lead level sampling
and analysis provided pursuant to this section shall have an accuracy (to a
confidence level of 95 percent) within plus or minus 15 percent or 6
µg/100ml, whichever is greater, and shall be conducted by a laboratory
licensed by the Center for Disease Control (CDC), U.S. Department of Health and
Human Services, or which has received a satisfactory grade in blood lead
proficiency testing from CDC in the prior 12 months.
(D) Employee Notification. Within five
working days after the receipt of biological monitoring results, the employer
shall notify in writing each employee whose blood lead level is at or above 40
µg/100 g:
1. Of that employee's blood
lead level; and
2. That the
standard requires temporary medical removal with Medical Removal Protection
benefits when an employee's blood lead level is at or above the numerical
criterion for medical removal under subsection
(k)(1).
(3)
Medical Examinations and Consultations.
(A)
Frequency. The employer shall make available medical examinations and
consultations to each employee covered under Section
5198(j)(1)(A) on
the following schedule:
1. At least annually
for each employee for whom a blood sampling test conducted at any time during
the preceding 12 months indicated a blood lead level at or above 40
µg/100 g;
2. Prior to
assignment for each employee being assigned for the first time to an area in
which 8-hour time-weighted concentrations of airborne lead ar at or above the
action level;
3. As soon as
possible, upon notification by an employee either that the employee has
developed signs or symptoms commonly associated with lead intoxication, that
the employee desires medical advice concerning the effects of current or past
exposure to lead on the employee's ability to procreate a healthy child, or
that the employee has demonstrated difficulty in breathing during a respirator
fitting test or during use; and
4.
As medically appropriate for each employee removed from exposure to lead due to
a risk of sustaining material impairment to health, or otherwise limited
pursuant to a final medical determination.
(B) Content. Medical examinations made
available pursuant to subsections (j)(3)(A)1-2 shall include the following
elements:
1. A detailed work history and a
medical history, with particular attention to past lead exposure (occupational
and non-occupational), personal habits (smoking, hygiene), and past
gastrointestinal, hematologic, renal, cardiovascular, reproductive and
neurological problems;
2. A
thorough physical examination, with particular attention to teeth, gums,
hematologic, gastrointestinal, renal, cardiovascular, and neurological systems.
Pulmonary status should be evaluated if respiratory protection will be
used;
3. A blood pressure
measurement;
4. A blood sample and
analysis which determines:
a. Blood lead
level;
b. Hemoglobin and hematocrit
determinations, red cell indices, and examination of peripheral smear
morphology;
c. Zinc
protoporphrin
d. Blood urea
nitrogen; and
e. Serum
creatinine.
5. A routine
urinalysis with microscopic examination; and
6. Any laboratory or other test which the
examining physician deems necessary by sound medical practice.
The content of medical examinations made available
pursuant to subsections (j)(3)(A)3-4 shall be determined by an examining
physician and, if requested by an employee, shall include pregnancy testing or
laboratory evaluation of male fertility.
(C) Multiple Physician Review Mechanism.
1. If the employer selects the initial
physician who conducts any medical examination or consultation provided to an
employee under this section, the employee may designate a second physician to
review any findings, determinations or recommendations of the initial physician
and to conduct such examinations, consultations, and laboratory tests as the
second physician deems necessary to facilitate this review.
2. The employer shall promptly notify an
employee of the right to seek a second medical opinion after each occasion that
an initial physician conducts a medical examination or consultation pursuant to
this section. The employer may condition participation in, and payment for, the
multiple physician review mechanism by requiring the employee (within 15 days
from the date of the foregoing notice or receipt of the initial physician's
written opinion, whichever is later) to inform the employer that the employee
intends to seek a second medical opinion and to initiate steps to make an
appointment with a second physician.
3. If the findings, determinations or
recommendations of the second physician differ from those of the initial
physician, then the employer and the employee shall assure that efforts are
made for the two physicians to resolve any disagreement.
4. If the two physicians are unable to
resolve their disagreement quickly, the employer and employee through their
respective physicians shall designate a third physician to review any findings,
determinations, or recommendations of the prior physicians and to conduct such
examinations, consultations, laboratory tests, and discussions with the prior
physicians which the third physician deems necessary to resolve the
disagreement of the prior physicians.
5. The employer shall act consistent with the
findings, determinations and recommendations of the third physician, unless the
employer and the employee reach an agreement which is otherwise consistent with
the recommendations of at least one of the three
physicians.
(D) Alternate
Physician Determination Mechanisms. The employer and an employee or authorized
employee representative may agree upon the use of any expeditious alternate
physician determination mechanism in lieu of the multiple physician review
mechanism provided by this section so long as the alternate mechanism otherwise
satisfies the requirements contained in this section.
(4) Information Provided to Examining and
Consulting Physicians:
(A) The employer shall
provide the following information to and initial physician conducting a medical
examination or consultation under the provisions of this section:
1. A copy of this regulation and its
appendices;
2. A description of the
affected employee's duties as they relate to the employee's exposure;
3. The employee's exposure level or
anticipated exposure level to lead and to any other toxic substance (if
applicable);
4. A description of
any personal protective equipment used or to be used;
5. Prior blood lead determinations;
and
6. All prior written medical
opinions concerning the employee in the employer's possession or
control.
(B) The employer
shall provide the foregoing information to a second or third physician
conducting a medical examination or consultation under this section upon
request either by the second or third physician, or by the
employee.
(5) Written
Medical Opinions.
(A) The employer shall
obtain and furnish the employee with a copy of a written medical report from
each examining or consulting physician which contains the following
information:
1. The physician's opinion as to
whether the employee has any detected medical condition which would place the
employee at increased risk of material impairment of the employee's health from
exposure to lead.
2. Any
recommended special protective measures to be provided to the employee, or
limitations to be placed upon the employee's exposure to lead.
3. Any recommended limitation upon the
employee's use of respirators, including a determination of whether the
employee can wear a powered air-purifying respirator if the physician
determines that the employee cannot wear a negative pressure respirator;
and
4. The results of the blood
lead determinations.
(B)
The employer shall instruct the examining physician to:
1. Not reveal either in the written opinion,
or in any other means of communication with the employer, findings, including
laboratory results, or diagnoses unrelated to the employee's occupational
exposure to lead; and
2. Advise the
employee of any medical condition, occupational or non-occupational, which
dictates further medical examination or
treatment.
(6)
Chelation.
(A) The employer shall assure that
any person whom he retains, employs, supervises, or controls does not engage in
prophylactic chelation of any employee at any time.
(B) If therapeutic or diagnostic chelation is
to be performed by any person in subsection (j)(6)(A), the employer shall
assure that it be done under the supervision of a licensed physician in a
clinical setting with thorough and appropriate medical monitoring and that the
employee is notified in writing prior to its
occurrence.
(k)
Medical Removal Protection.
(1) Temporary
Removal Due to Elevated Blood Lead Levels.
The employer shall remove an employee from work having
an exposure to lead at or above the action level on each occasion that the
average of the last three blood sampling tests conducted pursuant to this
section (or the average of all blood sampling tests conducted over the previous
six (6) months, whichever is longer) indicates that the employee's blood lead
level is at or above 50 µg/100 g of whole blood; provided, however, that
an employee need not be removed if the last blood sampling test indicates a
blood lead level below 40 µg/100 g of whole blood.
(2) Temporary Removal Due to a Final Medical
Determination.
(A) The employer shall remove
an employee from work having an exposure to lead at or above the action level
on each occasion that a final medical determination results in a medical
finding, determination, or opinion that the employee has a detected medical
condition which places the employee at increased risk of material impairment to
health from exposure to lead.
Note: For the purposes of this section,
the phrase "final medical determination" shall mean the outcome of the multiple
physician review mechanism or alternate physician determination mechanism used
pursuant to the medical surveillance provisions of this
section.
(B) Where a final
medical determination results in any recommended special protective measures
for an employee, or limitations on an employee's exposure to lead, the employer
shall implement and act consistent with the recommendation.
(3) Return of the Employee to Former Job
Status.
(A) The employer shall return an
employee to his or her former job status:
1.
For an employee removed due to a blood lead level at or above 50 µg/100 g
when two consecutive blood sampling tests indicate that the employee's blood
lead level is below 40 µg/100 g of whole blood; and
2. For an employee removed due to a final
medical determination, when a subsequent final medical determination results in
a medical finding, determination, or opinion that the employee no longer has a
detected medical condition which places the employee at increased risk of
material impairment to health from exposure to lead.
(B) For the purposes of this section, the
requirement that an employer return an employee to his or her former job status
is not intended to expand upon or restrict any rights an employee has or would
have had, absent temporary medical removal, to a specific job classification or
position under the terms of a collective bargaining
agreement.
(4) Removal of
Other Employee Special Protective Measures or Limitations.
The employer shall remove any limitations placed on an
employee or end any special protective measures provided to an employee
pursuant to a final medical determination when a subsequent final medical
determination indicates that the limitations or special protective measures are
no longer necessary.
(5)
Employer Options Pending a Final Medical Determination. Where the multiple
physician review mechanism, or alternate medical determination mechanism used
pursuant to the medical surveillance provisions of this section, has not yet
resulted in a final medical determination with respect to an employee, the
employer shall act as follows:
(A) Removal.
The employer may remove the employee from exposure to lead, provide special
protective measures to the employee, or place limitations upon the employee,
consistent with the medical findings, determinations, or recommendations of any
of the physicians who have reviewed the employee's health status.
(B) Return. The employer may return the
employee to his or her former job status, end any special protective measures
provided to the employee, and remove any limitations placed upon the employee,
consistent with the medical findings, determinations, or recommendations of any
of the physicians who have reviewed the employee's health status.
EXCEPTIONS:
1.
If the initial removal, special protection, or limitation of the employee
resulted from a final medical determination which differed from the findings,
determinations, or recommendations of the initial physician.
2. If the employee has been on removal status
for the preceding eighteen months due to an elevated blood lead level, the
employer shall await a final medical
determination.
(6) Medical Removal Protection Benefits.
(A) Provision of Medical Removal Protection
Benefits. The employer shall provide to an employee up to eighteen (18) months
of medical removal protection benefits on each occasion that an employee is
removed from exposure to lead or otherwise limited pursuant to this
section.
(B) Definition of Medical
Removal Protection Benefits. For the purposes of this section, the requirement
that an employer provide medical removal protection benefits means that the
employer shall maintain the earnings, seniority and other employment rights and
benefits of an employee as though the employee had not been removed from normal
exposure to lead or otherwise limited.
(C) Follow-Up Medical Surveillance During the
Period of Employee Removal or Limitation. During the period of time that an
employee is removed from normal exposure to lead or otherwise limited, the
employer may condition the provision of medical removal protection benefits
upon the employee's participation in follow-up medical surveillance made
available pursuant to this section.
(D) Worker's Compensation Claims. If a
removed employee files a claim for worker's compensation payments for a
lead-related disability, then the employer shall continue to provide medical
removal protection benefits pending disposition of the claim. To the extent
that an award is made to the employee for earnings lost during the period of
removal, the employer's medical removal protection obligation shall be reduced
by such amount. The employer shall receive no credit for worker's compensation
payments received by the employee for treatment related expenses.
(E) Other Credits. The employer's obligation
to provide medical removal protection benefits to a removed employee shall be
reduced to the extent that the employee receives compensation for earnings lost
during the period of removal either from a publicly or employer-funded
compensation program, or receives income from employment with another employer
made possible by virtue of the employee's removal.
(F) Employees Whose Blood Lead Levels Do Not
Adequately Decline Within 18 Months of Removal. The employer shall take the
following measures with respect to any employee removed from exposure to lead
due to an elevated blood lead level whose blood lead level has not declined
within the past eighteen (18) months of removal so that the employee has been
returned to his or her former job status.
1.
The employer shall make available to the employee a medical examination
pursuant to this section to obtain a final medical determination with respect
to the employee.
2. The employer
shall assure that the final medical determination obtained indicates whether or
not the employee may be returned to his or her former job status, and if not,
what steps should be taken to protect the employee's health.
3. Where the final medical determination has
not yet been obtained, or once obtained indicates that the employee may not yet
be returned to his or her former job status, the employer shall continue to
provide medical removal protection benefits to the employee until either the
employee is returned to former job status, or a final medical determination is
made that the employee is incapable of ever safely returning to his or her
former job status.
4. Where the
employer acts pursuant to a final medical determination which permits the
return of the employee to his or her former job status despite what would
otherwise be an unacceptable blood lead level, later questions concerning
removing the employee again shall be decided by a final medical determination.
The employer need not automatically remove such an employee pursuant to the
blood lead level removal criteria provided by this section.
(G) Voluntary Removal or Restriction of an
Employee. Where an employer, although not required by this section to do so,
removes an employee from exposure to lead or otherwise places limitations on an
employee due to the effects of lead exposure on the employee's medical
condition, the employer shall provide medical removal protection benefits to
the employee equal to that required by subsection
(k)(5)(A).
(l)
Employee Information and Training.
(1)
Training Program.
(A) Each employer who has a
workplace in which there is a potential exposure to airborne lead at any level
shall inform employees of the content of Appendices A and B of this
regulation.
(B) The employer shall
institute a training program for and assure the participation of all employees
who are subject to exposure to lead at or above the action level or for whom
the possibility exists of skin or eye irritation from exposure to
lead.
(C) The employer shall
provide initial training prior to the time of initial job assignment for those
employees subsequently covered by this paragraph.
(D) The training program shall be repeated at
least annually for each employee covered by subsection
(l)(1)(C).
(E) The
employer shall assure that each employee covered by subsection
(l)(1)(C) is informed of the following:
1. The content of this standard and its
appendices;
2. The specific nature
of the operations which could result in exposure to lead above the action
level;
3. The purpose, proper
selection, fitting, use, and limitations of respirators;
4. The purpose and a description of the
medical surveillance program, and the medical removal protection program
including information concerning the adverse health effects associated with
excessive exposure to lead (with particular attention to the adverse
reproduction effects on both males and females);
5. The engineering controls and work
practices associated with the employee's job assignment;
6. The contents of any compliance plan in
effect; and
7. Instructions to
employees that chelating agents should not routinely be used to remove lead
from their bodies and should not be used at all except under the direction of a
licensed physician.
(2) Access to Information and Training
Materials.
(A) The employer shall make a copy
of this standard and its appendices readily available to all affected employees
including employees exposed below the action level.
(B) The employer shall provide, upon request,
all materials relating to the employee information and training program to the
Chief.
(m)
Communication of Hazards.
(1) Hazard
Communication--General.
(A) Chemical
manufacturers, importers, distributors and employers shall comply with all
requirements of the Hazard Communication Standard (HCS) (Section
5194) for lead.
(B) In classifying the hazards of lead at
least the following hazards are to be addressed: Reproductive/developmental
toxicity; central nervous system effects; kidney effects; blood effects; and
acute toxicity effects.
(C)
Employers shall include lead in the hazard communication program established to
comply with the HCS (Section
5194). Employers shall ensure that
each employee has access to labels on containers of lead and to safety data
sheets, and is trained in accordance with the requirements of HCS and
subsection (l) of this section.
(2) Signs.
(A) The employer shall post the following
warning signs in each work area where the PEL is exceeded:
DANGER
LEAD MAY DAMAGE FERTILITY OR THE UNBORN
CHILD
CAUSES DAMAGE TO THE CENTRAL NERVOUS
SYSTEM
DO NOT EAT, DRINK OR SMOKE IN THIS
AREA
(B) The employer
shall ensure that no statement appears on or near any sign required by this
subsection (m)(2) which contradicts or detracts from the meaning of the
required sign.
(C) The employer
shall ensure that signs required by this subsection (m)(2) are illuminated and
cleaned as necessary so that the legend is readily visible.
(D) The employer may use signs required by
other statutes, regulations, or ordinances in addition to, or in combination
with, signs required by this subsection (m)(2).
(E) Prior to June 1, 2016, employers may use
the following legend in lieu of that specified in subsection (m)(2)(B) of this
section:
WARNING
LEAD WORK AREA
POISON
NO SMOKING OR
EATING
(n) Recordkeeping.
(1) Exposure Monitoring.
(A) The employer shall establish and maintain
an accurate record of all monitoring required in subsection (d).
(B) This record shall include:
1. The date(s), number, duration, location
and results of each of the samples taken, including a description of the
sampling procedure used to determine representative employee exposure where
applicable;
2. A description of the
sampling and analytical methods used and evidence of their accuracy;
3. The type of respiratory protective devices
worn, if any;
4. Name, social
security number, and job classification of the employee monitored and of all
other employees whose exposure the measurement is intended to represent;
and
5. The environmental variables
that could affect the measurement of employee exposure.
(C) The employer shall maintain these
monitoring records for at least 40 years or for the duration of employment plus
20 years, whichever is longer.
(2) Medical Surveillance.
(A) The employer shall establish and maintain
an accurate record for each employee subject to medical surveillance as
required by subsection (j).
(B)
This record shall include:
1. The name, social
security number, and description of the duties of the employee;
2. A copy of the physician's written
opinions;
3. Results of any
monitoring of exposure to airborne lead done for that employee and the
representative exposure level supplied to the physician; and
4. Any employee medical complaints related to
exposure to lead.
(C) The
employer shall keep, or assure that the examining physician keeps, the
following medical records:
1. A copy of the
medical examination results including medical and work history required under
subsection (j).
2. A description of
the laboratory procedures and a copy of any standards or guidelines used to
interpret the test results or references to that information.
3. A copy of the results of biological
monitoring.
(D) The
employer shall maintain or assure that the physician maintains those medical
records for at least 40 years, or for the duration of employment plus 20 years,
whichever is longer.
(3)
Medical Removals.
(A) The employer shall
establish and maintain an accurate record for each employee removed from
current exposure to lead pursuant to subsection (k).
(B) Each record shall include:
1. The name and social security number of the
employee;
2. The date on each
occasion that the employee was removed from current exposure to lead as well as
the corresponding date on which the employee was returned to his or her former
job status;
3. A brief explanation
of how each removal was or is being accomplished; and
4. A statement with respect to each removal
indicating whether or not the reason for the removal was an elevated blood lead
level.
(C) The employer
shall maintain each medical removal record for at least the duration of an
employee's employment.
(4) Availability.
(A) The employer shall make available upon
request all records required to be maintained by this subsection to the Chief
and the Director for examination and copying.
(B) Environmental monitoring, medical
removal, and medical records required by this section shall be provided upon
request to employees, designated representatives, and authorized
representatives of the Chief in accordance with Section
3204. Medical removal records shall
be provided as prescribed by Section
3204 for monitoring
records.
(5) Transfer of
Records.
(A) Whenever the employer ceases to
do business, the successor employer shall receive and retain all records
required to be maintained by subsection (n).
(B) Whenever the employer ceases to do
business and there is n successor employer to receive and retain the records
required to be maintained by this section for the prescribed period, these
records shall be transmitted to the Director.
(C) At the expiration of the retention period
for the records required to be maintained by this section, the employer shall
notify the Director at least 3 months prior to the disposal of such records and
shall transmit those records to the Director if requested within the
period.
(D) The employer shall also
comply with any additional requirements involving the transfer of records set
forth in Section
3204.
(o) Observation of Monitoring. During any
observation of monitoring under subsection (d) by an affected employee or
employees or their representative (pursuant to Section
340.1) in an area where the use of
respirators, protective clothing or equipment is required, the employer shall
provide the observer with, and assure the use of, such respirators, clothing
and equipment and shall require the observer to comply with all other
applicable safety and health procedures. Without interfering with the
monitoring, the observer shall be entitled to receive an explanation of the
measurement procedures used.
(p)
Appendices. The information contained in the appendices to this section is not
intended to create any additional obligations not otherwise imposed by this
standard nor detract from any existing obligation.
1.
Change without regulatory effect renumbering section
5216 and appendices A-D to section
5198 filed 2-16-2000 pursuant to section
100, title 1, California Code of
Regulations (Register 2000, No. 7). For prior history, see Register 87, No.
51.
2. Change without regulatory effect amending subsection
(j)(3)(A) filed 6-26-2000 pursuant to section
100, title 1, California Code of
Regulations (Register 2000, No. 26).
3. Amendment of subsection
(f)(2)(A) filed 7-31-2003; operative 8-30-2003 (Register 2003, No.
31).
4. Amendment of subsection (f)(3)(A) and new subsections
(f)(3)(C)-(D) filed 3-6-2007; operative 3-6-2007. Submitted to OAL for printing
only pursuant to Labor Code section
142.3(a)(3)
(Register 2007, No. 10).
5. Change without regulatory effect
amending subsection (f)(2)(A) filed 12-1-2008 pursuant to section
100, title 1, California Code of
Regulations (Register 2008, No. 49).
6. Amendment of subsections
(j)(2)(B), (j)(2)(D), (k)(1) and (k)(3)(A)1. filed 1-18-2012; operative
1-18-2012 pursuant to Labor Code section
142.3(a)(4)(C).
Submitted to OAL for printing only pursuant to Labor Code section
142.3(a)(3)
(Register 2012, No. 3).
7. Amendment of subsection (j)(2)(D)2. filed
9-4-2012; operative 10-4-2012 (Register 2012, No. 36).
8. Amendment
of subsection (g)(2)(G), new subsections (g)(2)(G)1.-2., repealer and new
subsections (m)-(m)(1)(B), new subsection (m)(1)(C), amendment of subsection
(m)(2)(A), repealer and new subsection (m)(2)(B), new subsections
(m)(2)(C)-(E), amendment of NOTE and amendment of Appendix B, item XI. filed
5-6-2013; operative 5-6-2013 pursuant to Labor Code section
142.3(a)(4)(C).
Submitted to OAL for printing only pursuant to Labor Code section
142.3(a)(4)
(Register 2013, No. 19).
9. Amendment of subsection (g)(2)(G), new
subsections (g)(2)(G)1.-2., repealer and new subsections (m)-(m)(1)(B), new
subsection (m)(1)(C), amendment of subsection (m)(2)(A), repealer and new
subsection (m)(2)(B), new subsections (m)(2)(C)-(E), amendment of NOTE and
amendment of Appendix B, item XI. refiled 11-6-2013; operative 11-6-2013
pursuant to Labor Code section
142.3(a)(4)(C).
Submitted to OAL for printing only pursuant to Labor Code section
142.3(a)(4)
(Register 2013, No. 45).
10. Repealer of 11-6-2013 order by
operation of law 5-6-2014 pursuant to Labor Code 142.3 (Register 2014, No.
19).
11. Amendment of subsection (g)(2)(G), new subsections
(g)(2)(G)1.-2., repealer and new subsections (m)-(m)(1)(B), new subsection
(m)(1)(C), amendment of subsection (m)(2)(A), repealer and new subsection
(m)(2)(B), new subsections (m)(2)(C)-(E), amendment of NOTE and amendment of
Appendix B, item XI. filed 5-5-2014; operative 5-6-2014 pursuant to Government
Code section
11343.4(b)(3)
(Register 2014, No. 19).
Note: Authority cited: Section
142.3, Labor
Code. Reference: Section
142.3, Labor
Code; and Federal Register Volume 77, Number 58 (Monday, March 26, 2012) Pages
17574-17896.